Cambridge Investment Research Advisors, Inc. Anixa Biosciences Inc Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 41,104 shares of ANIX stock, worth $110,569. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,104
Previous 41,000
0.25%
Holding current value
$110,569
Previous $91,000
41.76%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ANIX
# of Institutions
60Shares Held
5.56MCall Options Held
21KPut Options Held
6.7K-
Vanguard Group Inc Valley Forge, PA1.39MShares$3.75 Million0.0% of portfolio
-
D.A. Davidson & Co.671KShares$1.81 Million0.02% of portfolio
-
Laird Norton Trust Company, LLC621KShares$1.67 Million0.26% of portfolio
-
Ubs Group Ag529KShares$1.42 Million0.0% of portfolio
-
Mission Wealth Management, LP510KShares$1.37 Million0.04% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $82.5M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...